1228 Phase I study of NGR-hTNF, a vascular targeting agent...

1228 Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours

G. Citterio, F.G. De Braud, V. Gregorc, T.M. De Pas, C. Noberasco, S. Boselli, M. Giovannini, F. Caligaris Cappio, A. Lambiase, C. Bordignon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)70440-9
File:
PDF, 51 KB
english, 2009
Conversion to is in progress
Conversion to is failed